ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

Weicker Negotiating For 6,000 NIH Grants In Both 1985, 1986; Societies Appeal For Adequate Funding

May 10, 1985

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008